BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12456342)

  • 1. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression.
    Osteen KG; Igarashi TM; Bruner-Tran KL
    Front Biosci; 2003 Jan; 8():d78-86. PubMed ID: 12456342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.
    Osteen KG; Bruner-Tran KL; Ong D; Eisenberg E
    Ann N Y Acad Sci; 2002 Mar; 955():139-46; discussion 157-8, 396-406. PubMed ID: 11949943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium.
    Osteen KG; Keller NR; Feltus FA; Melner MH
    Gynecol Obstet Invest; 1999; 48 Suppl 1():2-13. PubMed ID: 10559659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.
    Osteen KG; Bruner-Tran KL; Keller NR; Eisenberg E
    Ann N Y Acad Sci; 2002 Mar; 955():37-47; discussion 86-8, 396-406. PubMed ID: 11949963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs).
    Henriet P; Cornet PB; Lemoine P; Galant C; Singer CF; Courtoy PJ; Eeckhout Y; Marbaix E
    Ann N Y Acad Sci; 2002 Mar; 955():119-38; discussion 157-8, 396-406. PubMed ID: 11949942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
    Osteen KG; Bruner-Tran KL; Eisenberg E
    Fertil Steril; 2005 Mar; 83(3):529-37. PubMed ID: 15749474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
    Zhang J; Hampton AL; Nie G; Salamonsen LA
    Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
    Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
    Bruner-Tran KL; Eisenberg E; Yeaman GR; Anderson TA; McBean J; Osteen KG
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4782-91. PubMed ID: 12364474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis.
    Bruner KL; Eisenberg E; Gorstein F; Osteen KG
    Steroids; 1999 Sep; 64(9):648-53. PubMed ID: 10503723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.
    Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M
    Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium.
    Cornet PB; Galant C; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1001-11. PubMed ID: 15536155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
    Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases.
    Cornet PB; Picquet C; Lemoine P; Osteen KG; Bruner-Tran KL; Tabibzadeh S; Courtoy PJ; Eeckhout Y; Marbaix E; Henriet P
    J Biol Chem; 2002 Nov; 277(45):42496-504. PubMed ID: 12215426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients.
    Rudolph-Owen LA; Slayden OD; Matrisian LM; Brenner RM
    Biol Reprod; 1998 Dec; 59(6):1349-59. PubMed ID: 9828178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation.
    Zhang J; Salamonsen LA
    J Clin Endocrinol Metab; 2002 May; 87(5):2346-51. PubMed ID: 11994386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
    Tunuguntla R; Ripley D; Sang QX; Chegini N
    Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; BĂ©liard A; Fridman V; Nervo P; Colige A; Foidart JM
    Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.